Prebiotics

Chemical and Functional Properties of Food Components, Third Edition

Volumn , Issue , 2006, Pages 391-411

  Rastall, Bob ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACIDS; METABOLISM; NUTRIENTS; PHYSIOLOGY;

ANAEROBIC ENVIRONMENT; BACTERIAL METABOLISM; BACTERIAL POPULATION; COLONIC MICROBIOTA; COMPLEX ECOSYSTEMS; HUMAN DIGESTIVE TRACT; PHENOLIC COMPOUNDS; PRIMARY PRODUCTS;

BACTERIA;

EID: 80054709775     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (92)

1. Roberfroid, M. Functional food concept and its application to prebiotics. Digestive and Liver Disease 34, S105, 2002.
2. Gibson G.R. et al. Probiotics and intestinal infections, in Probiotics 2: Applications and Practical Aspects. Fuller, R., Ed. Chapman and Hall, London, 1997, p. 10.
3. Gibson G.R. and Wang, X. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J. Appl. Bacteriol. 77, 412, 1994.
4. Bovee-Oudenhoven, I.M.J. et al. Increasing the intestinal resistance of rats to the invasive pathogen Salmonella enteritidis: additive effects of dietary lactulose and calcium. Gut 40, 497, 1997.
5. Bovee-Oudenhoven, I.M.J. et al. Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation of Salmonella in rats. Gut 52, 1572, 2003.
6. Asahara, T. et al. Increased resistance of mice to Salmonella enteritica serovar Typhymurium infection by synbiotic administration of bifidobacteria and transgalactosylated- oligosaccharides. Journal of Applied Microbiology 91, 985, 2001.
7. Buddington, K.K, Danohoo, J.B., and Buddington, R.K. Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumour inducers. Journal of Nutrition 132, 472, 2002.
8. Cummings, J.H., Christie, S., and Cole, T.J. A study of fructooligosaccharides in the prevention of travellers’ diarrhoea. Alimentary Pharmacology and Therapeutics 15, 1139, 2001.
9. Lewis, S. et al. Failure of dietary oligofructose to prevent antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 21, 469, 2005.
10. Ito, M. et al. Effects of administration of galactooligosaccharide on the human faecal microflora, stool weight and abdominal sensation. Microbial Ecology in Health and Disease 3, 285, 1990.
11. Burns, A.J. and Rowland, I.R. Anti-carcinogenicity of probiotics and prebiotics. Current Issues in Intestinal Microbiology 1, 13, 2000.
12. McBain, A.J. and Macfarlane, G.T. Modulation of genotoxic enzyme activities by non-digestible oligosaccharide metabolism in in-vitro human gut bacterial systems. Journal of Medical Microbiology 50, 833, 2001.
13. Tuohy, K.M. et al. A human volunteer study to determine the prebiotic effects of lactulose powder on human colonic microbiota. Microbial Ecology in Health and Disease 14, 165, 2002.
14. Bouhnik, Y. et al. Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. European Journal of Clinical Nutrition 58, 462, 2004.
15. Terada, A. et al. Effect of lactulose on the composition and metabolic activity of human faecal flora. Microbial Ecology in Health and Disease 5, 43, 1992.
16. Ballongue, J., Schumann, C., and Quignon, P. Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scandinavian Journal of Gastroenterology, 32 Suppl. 222, 41, 1997.
17. 4] tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers. British Journal of Nutrition 92, 439, 2004.
18. Challa, A. et al. Bifidobacterium longum and lactulose suppress azoxymethaneinduced colonic aberrant crypt foci in rats. Carcinogenesis 18, 517, 1997.
19. Rowland, I.R. et al. The effect of lactulose on DNA damage induced by DMH in the colon of human flora-associated rats. Nutrition and Cancer 26, 37, 1996.
20. Femia, A.P. et al. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis 23, 1953, 2002.
21. Ponz de Leon, M. and Roncucci, L. Chemoprevention of colorectal tumours: role of lactulose and of other agents. Scandinavian Journal of Gastroenterology 32 Suppl. 222, 72, 1997.
22. Van Loo, J. and Jonkers, N. Evaluation in human volunteers of the potential anticarcinogenic activities of novel nutritional concepts: prebiotics probiotics and synbiotics (the SYNCAN project). Nutr. Metab. Cardiovasc. Dis. 11, S4, 87, 2001.
23. Klinder, A. et al. Gut fermentation products of chicory inulin-derived prebiotics inhibit markers of tumour progression in human colon tumour cells. Journal of Cancer Prevention 1, 19, 2004.
24. Imaizumi, K. et al. Effects of xylooligosaccharides on blood glucose, serum and liver lipids and caecum short-chain fatty acids in diabetic rats. Agriculture Biology and Biochemistry 55, 199, 1991.
25. Bornet, F.R.J. et al. Nutritional aspect of short-chain fructooligosaccharides: natural occurrence, chemistry, physiology and health implications. Digestive and Liver Disease 34, S111, 2002.
26. Wolever, T.M.S., Spadafora, P., and Eshuis, H. Interaction between colonic acetate and propionate in humans. American Journal of Clinical Nutrition 53, 681, 1991.
27. Rycroft, C.E. et al. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. Journal of Applied Microbiology 91, 878, 2001.
28. Palframan, R., Gibson, G.R., and Rastall, R.A. Effect of pH and dose on the growth of gut bacteria on prebiotic carbohydrates in vitro, Anaerobe 8, 287, 2002.
29. Sanz, M.L., Gibson, G.R., and Rastall, R.A. Influence of disaccharide structure on the prebiotic effect using a reduced scale in vitro fermentation system. Journal of Agricultural and Food Chemistry 53, 5192, 2005.
30. Molly, K., Vande Woestyne, M., and Verstraete, W. Development of a 5-step multichamber reactor as a simulation of the human intestinal microbial ecosystem. Appl. Microbiol. Biotech. 39, 254, 1993.
31. Macfarlane, G.T., Macfarlane, S., and Gibson, G.R. Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microbial Ecology 35, 180, 1998.
32. Greetham, H.L. et al. Bacteriology of the Labrador dog gut: a cultural and genotypic approach. Journal of Applied Microbiology 93, 640, 2002.
33. Blaut, M. et al. Molecular biological methods for studying the gut microbiota: the EU human gut flora project. British Journal of Nutrition 87 Suppl. 2, S203, 2002.
34. Franks, A.H. et al. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Applied and Environmental Microbiology 64, 3336, 1998.
35. Zoetendal, E.G. et al. Quantification of uncultured Ruminococcus obeum-like bacteria in human fecal samples by fluorescent in situ hybridization and flow cytometry using 16S rRNA-targeted probes. Applied and Environmental Microbiology 68, 4225, 2002.
36. Matsuki, T. et al. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Applied and Environmental Microbiology 70, 167, 2004.
37. Gibson, G.R. et al. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutrition Research Reviews 17, 259, 2004.
38. Marx, S.P., Winkler, S., and Hartmeier, W., Metabolization of beta-(2,6)-linked fructose- oligosaccharides by different bifidobacteria, FEMS Microbiology Letters 182, 163, 2000.
39. Wang, X. and Gibson, G.R. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine, Journal of Applied Bacteriology 75, 373, 1993.
40. Probert, H.M. and Gibson, G.R. Investigating the prebiotic and gas-generating effects of selected carbohydrates on the human colonic microflora, Letters in Applied Microbiology 35, 473, 2002.
41. Campbell, J.M., Fahey, G.C., Jr., and Wolf, B.W. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats, Journal of Nutrition 127, 130, 1997.
42. Kleessen, B., Hartmann, L., and Blaut, M. Oligofructose and long-chain inulin:influence on the gut microbial ecology of rats associated with a human faecal flora, British Journal of Nutrition 86, 291, 2001.
43. Poulsen, M., Molck, A.M., Jacobsen, B.L. Different effects of short- and long-chained fructans on large intestinal physiology and carcinogen-induced aberrant crypt foci in rats, Nutrition and Cancer 42, 194, 2002.
44. Kruse, H.P., Kleessen, B., and Blaut, M. Effects of inulin on faecal bifidobacteria in human subjects, British Journal of Nutrition 82, 375, 1999.
45. Tuohy, K., et al. A human volunteer study on the prebiotic effects of HP inulin- faecal bacteria enumerated using fluorescent in situ hybridisation (FISH). Anaerobe 7, 113, 2001.
46. Harmsen, H.J. et al. The effect of the prebiotic inulin and the probiotic Bifidobacterium longum on the fecal microflora of healthy volunteers measured by FISH and DGGE. Microbial Ecology in Health and Disease 14, 211, 2002.
47. Albayrak, N. and Yang, S.-T. Immobilization of β-galactosidase on fibrous matrix by polyethyleneimine for production of galacto-oligosaccharides from lactose. Biotechnology Progress 18, 240, 2002.
48. Rabiu, B.A. et al. Synthesis and fermentation properties of novel galactooligosaccharides by β-galactosidases from Bifidobacterium spp. Applied and Environmental Microbiology 67, 2526, 2001.
49. Zárate, S. and López-Leiva, M.H. Oligosaccharide formation during enzymatic lactose hydrolysis: A literature review. Journal of Food Protection 53, 262, 1990.
50. Burvall, A., Asp, N.-G., and Dahlqvist, A. Oligosaccharide formation during hydrolysis of lactose with S. lactis lactase (Maxilact): Part III: Digestibility by human intestinal enzymes in vitro. Food Chemistry 5, 189, 1980.
51. Tanaka, R. et al. Effects of administration of TOS and Bifidobacterium breve 4006 on the human fecal flora. Bifidobacteria Microflora 2, 17, 1983.
52. Alles, M.S. et al. Effect of transgalactooligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer. American Journal of Clinical Nutrition 69, 980, 1999.
53. Tzortzis, G., Goulas, A.K., and Gibson, G.R. Synthesis of prebiotic galactooligosaccharides using whole cells of a novel strain Bifidobacterium bifidum NCIMB 41171. Applied Microbiology and Biotechnology 68, 412, 2005.
54. Tzortzis, G., et al. A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous n vitro fermentation system and in the proximal colonic contents of pigs in vivo. Journal of Nutrition 135, 1726, 2005.
55. Alander, M. et al. Effect of galacto-oligosaccharides supplementation on human faecal microflora and on survival and persistence on Bifidobacterium lactis Bb-12 in the gastrointestinal tract. International Dairy Journal 11, 817, 2001.
56. Satokari, R.M. et al. Polymerase chain reaction and denaturing gradient gel electrophoresis monitoring of fecal Bifidobacterium populations in a prebiotic and probiotic feeding trial. Systemic and Applied Microbiology 24, 227, 2001.
57. Roberfroid, M.B., Van Loo, J.A.E., and Gibson G.R. The bifidogenic nature of chicory inulin and its hydrolysis products. The Journal of Nutrition 128, 11, 1998.
58. Harju, M. Lactulose as a substrate for β-galactosidases I. Milchwissenschaft 41, 281, 1986.
59. Playne, M.J., and Crittenden, R. Commercially available oligosaccharides. Bulletin of the International Dairy Federation 313, 10, 1996.
60. Oku, T. and Nakamura, S. Comparison of digestibility and breath hydrogen gas excretion of fructo-oligosaccharide, galactosyl-sucrose, and isomalto-oligosaccharide in healthy human subjects. European Journal of Clinical Nutrition 57, 1150, 2003.
61. Kohmoto, T. et al. Effect of isomalto-oligosaccharides on human faecal flora. Bifidobacteria Microflora 7, 61, 1998.
62. Kaneko, T. et al. Effects of isomaltooligosaccharides with different degrees of polymerisation on human fecal bifidobacteria. Bioscience, Biotechnology and Biochemistry 58, 2288, 1994.
63. Hayakawa, K. et al. Effects of soybean oligosaccharides on human faecal microflora. Microbial Ecology in Health and Disease 3, 293, 1990.
64. Wada, K. et al. Effects of soybean oligosaccharides in a beverage on human fecal flora and metabolites. Journal of the Agricultural Chemistry Society of Japan 66, 127, 1992.
65. Hara, T. et al. Effects of small amount ingestion of soybean oligosaccharides on bowel habits and fecal flora of volunteers. Japanese Journal of Nutrition 55, 79, 1997.
66. Rycroft, C.E. et al. Fermentation properties of gentio-oligosaccharides. Letters in Applied Microbiology 32, 156, 2001.
67. Sanz, M.L. et al. Selective fermentation of gentiobiose derived oligosaccharides by human gut bacteria: Influence of molecular weight. FEMS Microbiology Ecology, In Press 56, 383-388, 2006.
68. Jaskari, J. et al. Oat β-glucan and xylan hydrolysates as selective substrates for Bifidobacterium and Lactobacillus strains. Applied Microbiology and Biotechnology 49, 175, 1998.
69. van Laere, K.M. et al. Fermentation of plant cell wall derived polysaccharides and their corresponding oligosaccharides by intestinal bacteria. Journal of Agricultural and Food Chemistry 48, 1644, 2000.
70. Okazaki, M., Fujikawa, S., and Matsumomo, N. Effect of xylooligosaccharide on the growth of bifidobacteria. Bifidobacteria Microflora 9, 77, 1990.
71. Olano-Martin, E. et al. Continuous production of oligosaccharides from pectin in an enzyme membrane reactor. Journal of Food Science 66, 966, 2001.
72. Hotchkiss, A.T., Jr. et al. Pectic oligosaccharides as prebiotics, in Oligosaccharides in Food and Agriculture Eggleston, G. and Cote, G., Eds. ACS Symposium series, American Chemical Society, Washington, DC, 2003,849, 54.
73. Olano-Martin, E., Gibson, G.R., and Rastall, R.A. Comparison of the n vitro bifidogenic properties of pectins and pectic oligosaccharides. Journal of Applied Microbiology 93, 505, 2002.
74. Manderson, K. et al. In vitro determination of the prebiotic properties of oligosaccharides derived from an orange juice manufacture byproduct stream. Applied and Environmental Microbiology 71, 8383, 2005.
75. Mountzouris, K.C. et al. A study of dextran production from maltodextrin by cell suspensions of Gluconobacter oxydans NCIB 4943. Journal of Applied Microbiology 87, 546, 1999.
76. Wichienchot, S. et al. In vitro fermentation of mixed linkage gluco-oligosaccharides produced by Gluconobacter oxydans NCIMB 4943 by the human colonic microflora. Current Issues in Intestinal Microbiology 7, 7, 2005.
77. Wichienchot, S. et al. In vitro three-stage continuous fermentation of gluco-oligosaccharides produced by Gluconobacter oxydans NCIMB 4943 by the human colonic microflora. Current Issues in Intestinal Microbiology 7, 13, 2005.
78. Côté, G.L., Holt, S.M., and Miller-Fosmore, C. Prebiotic oligosaccharides via alternansucrase acceptor reactions, in Oligosaccharides in Food and Agriculture Eggleston, G. and Côté, G.L., Eds. ACS Symposium Series, American Chemical Society, Washington, DC, 2003, p. 75.
79. Holt, S.M., Miller-Fosmore, C.M., and Côté, G.L. Growth of various intestinal bacterial on alternansucrase-derived oligosaccharides. Letters in Applied Microbiology 40, 385, 2005.
80. Sanz, M.L. et al. Prebiotic properties of alternansucrase maltose-acceptor oligosaccharides. Journal of Agricultural and Food Chemistry 53, 5911, 2005.
81. Likotrafiti, E. et al. Molecular identification and anti-pathogen potential of putative probiotic bacteria isolated from faecal samples taken from healthy independent elderly individuals. Microbial Ecology in Health and Disease 16, 105, 2004.
82. Conway P.L. Microbial ecology of the human large intestine, in Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology Gibson, G.R. and Macfarlane, G.T., Eds. CRC Press, Boca Raton, FL, 1995, p. 1.
83. Buddington, R.K., et al. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. American Journal of Clinical Nutrition 63, 709, 1996.
84. Willis, C.L. et al. Nutritional aspects of dissimilatory sulfate reduction in the human large intestine. Current Microbiology 35, 294, 1997.
85. Pitcher, M.C. and Cummings, J.H. Hydrogen sulphide: a bacterial toxin in ulcerative colitis? Gut 39, 1, 1996.
86. Sharon, N. and Ofek, I. Safe as mother’s milk: Carbohydrates as future anti-adhesion drugs for bacterial diseases. Glycoconjugate Journal 17, 659, 2000.
87. Zopf, D., and Roth, S. Oligosaccharide anti-infective agents. Lancet 347, 1017, 1996.
88. Isoda, H. et al. Use of compounds containing or binding sialic acid to neutralise bacterial toxins. European Patent 385112, 1999.
89. Brück, W.B. et al. rRNA probes used to quantify the effects of glycomacropeptide and α-lactalbumin supplementation on the predominant groups of intestinal microflora of infant rhesus monkeys challenged with enteropathogenic Escherichia coli. Journal of Pediatric Gastroenterology Nutrition 37, 273, 2003.
90. Rhoades, J.R. et al. Caseinoglycomacropeptide inhibits adhesion of pathogenic Escherichia coli strains to human cells in culture. Journal of Dairy Science 88, 3455, 2005.
91. Guggenbichler, J.P. et al. Acidic oligosaccharides form natural sources block adherence of Escherichia coli on uroepithelial cells. Pharmaceutical and Pharmacological Letters 1, 35, 1997.
92. Olano-Martin, E. et al. Pectins and pectic-oligosaccharides inhibit Escherichia coli O157:H7 Shiga toxin as directed towards the human colonic cell line HT29. FEMS Microbiology Letters 218, 101, 2003.